`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE EASTERN DISTRICT OF TEXAS
`MARSHALL DIVISION
`
`
`
`
`
`
`
`CIVIL ACTION NO. 2:20-CV-00337-JRG
`
`
`
`
`
`
`§
`§
`§
`§
`§
`§
`§
`§
`§
` §
` §
` §
` §
` §
`
`
`ORDER
`Before the Court is the Motion to Expedite Consideration of Defendants’ Opposed Motion
`
`SEAGEN INC.,
`
`
`
`v.
`
`DAIICHI SANKYO CO., LTD.,
`
`
`
`ASTRAZENECA PHARMACEUTICALS
`LP, and ASTRAZENECA UK LTD
`
`
`
`
`
`
`Plaintiff,
`
`
`
`
`
`Defendant,
`
`Intervenor-Defendants.
`
`
`
`
`
`Under Entry of Judgment Federal Rules of Civil Procedure 52(b) and 59(e) to Amend or Add
`
`Findings of Fact and Alter or Amend the Judgment (ECF No. 499) (the “Motion to Expedite”)
`
`filed by Plaintiff Seagen Inc. (“Seagen”). (Dkt. No. 506). In the Motion to Expedite, Seagen
`
`requests that the Court expedite its consideration of Defendants’ Opposed Motion Under Federal
`
`Rules of Civil Procedure 52(b) and 59(e) to Amend or Add Findings of Fact and Alter or Amend
`
`the Judgment (Dkt. No. 499) (the “Motion to Amend”). (Dkt. No. 506 at 2). Seagen contends that
`
`the apparent purpose of the Motion to Amend is “simply to delay the final disposition of this case
`
`at the district court level and effectively disrupt the appellate process.” (Id.). Seagen filed the
`
`Motion to Expedite as opposed. (Id. at 4).
`
`Having considered the Motion to Expedite, and noting the lack of compelling reasons
`
`contained therein that would necessitate the Court’s expeditious review, the Court finds that the
`
`
`
`Case 2:20-cv-00337-JRG Document 507 Filed 10/02/23 Page 2 of 2 PageID #: 21633
`
`Motion to Expedite should be and hereby is DENIED. The Court will address the Motion to
`
`Amend in due course and consistent with the Court’s other obligations.
`
`
`
`
`
`2
`
`.
`
`____________________________________
`RODNEY GILSTRAP
`UNITED STATES DISTRICT JUDGE
`
`So ORDERED and SIGNED this 2nd day of October, 2023.
`
`